|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 39/39 | |
| A61K 9/127 | |||
| A61K 9/00 |
| (11) | Patento numeris | 1432442 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02777259.9 |
| Europos patento paraiškos padavimo data | 2002-09-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-06-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2002/010931 |
| Data | 2002-09-30 |
| (87) | Numeris | WO 2003/028760 |
| Data | 2003-04-10 |
| (30) | Numeris | Data | Šalis |
| 0123580 | 2001-10-01 | GB |
| (72) |
GARCON, Nathalie c/o GlaxoSmithKline Beecham, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | The use of liposomes containing saponins and sterols in the manufacture of intradermal vaccines |
| The use of liposomes containing saponins and sterols in the manufacture of intradermal vaccines |